MedTrace Logo

Long-Term Lithium Treatment for Aggressive Conduct Disorder

NCT00000385 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2013-11-26

No results posted yet for this study

Summary

This study will examine the long-term effects of lithium used to treat children and adolescents with aggressive conduct disorder (severe aggression).

Conditions

  • Conduct Disorder
  • Aggression

Interventions

DRUG

Lithium

Lithium 600 mg to 2700 mg per day

DRUG

Placebo

Matching placebo

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Drexel University

    lead OTHER

Principal Investigators

  • Richard P. Malone, MD · Drexel University College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-09-30
Primary Completion
2003-12-31
Completion
2005-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000385 on ClinicalTrials.gov